Hideki Hasegawa

18.5k total citations · 3 hit papers
398 papers, 11.5k citations indexed

About

Hideki Hasegawa is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Hideki Hasegawa has authored 398 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Epidemiology, 110 papers in Immunology and 91 papers in Infectious Diseases. Recurrent topics in Hideki Hasegawa's work include Influenza Virus Research Studies (105 papers), Semiconductor materials and devices (77 papers) and Respiratory viral infections research (58 papers). Hideki Hasegawa is often cited by papers focused on Influenza Virus Research Studies (105 papers), Semiconductor materials and devices (77 papers) and Respiratory viral infections research (58 papers). Hideki Hasegawa collaborates with scholars based in Japan, United States and Ireland. Hideki Hasegawa's co-authors include Hideo Ohno, Tadaki Suzuki, Tetsutaro Sata, Noriyo Nagata, Takeshi Kurata, Akira Ainai, Yuko Sato, Naoko Iwata‐Yoshikawa, Hirofumi Sawa and Takeshi Ichinohe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Hideki Hasegawa

385 papers receiving 11.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gold Nanoparticles as a Vaccine Platform: Influence of Size and Shape on Immunological Responses in Vitro and in Vivo

2013 524 citations Tadaki Suzuki, Yasuko Orba et al. profile →
TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection

2019 489 citations Naoko Iwata‐Yoshikawa, Hideki Hasegawa et al. Journal of Virology profile →
Unified disorder induced gap state model for insulator–semiconductor and metal–semiconductor interfaces

1986 392 citations Hideki Hasegawa et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hideki Hasegawa Japan	54	3.2k	3.1k	3.1k	2.4k	1.6k	398	11.5k
Dimiter S. Dimitrov United States	74	3.2k 1.0×	6.4k 2.0×	5.6k 1.8×	7.1k 2.9×	528 0.3×	364	20.7k
Achim D. Gruber Germany	57	1.4k 0.4×	2.4k 0.8×	1.2k 0.4×	3.9k 1.6×	801 0.5×	322	13.4k
Takashi Suzuki Japan	59	4.1k 1.3×	1.8k 0.6×	1.4k 0.5×	3.9k 1.6×	422 0.3×	527	12.5k
José L. Carrascosa Spain	59	1.6k 0.5×	661 0.2×	1.1k 0.4×	4.9k 2.0×	286 0.2×	217	9.6k
Dieter Blaas Austria	49	2.0k 0.6×	820 0.3×	1.3k 0.4×	3.2k 1.3×	322 0.2×	178	7.6k
Jamie J. Arnold United States	41	948 0.3×	360 0.1×	2.0k 0.7×	2.7k 1.1×	1.5k 1.0×	94	7.2k
Abraham J. Koster Netherlands	66	878 0.3×	1.5k 0.5×	1.9k 0.6×	5.7k 2.4×	370 0.2×	184	13.3k
Timothy S. Baker United States	74	2.9k 0.9×	880 0.3×	5.8k 1.9×	6.2k 2.5×	146 0.1×	211	17.4k
Robert Wilson United Kingdom	58	859 0.3×	1.3k 0.4×	596 0.2×	4.5k 1.8×	684 0.4×	250	11.9k
Ren Sun United States	53	5.0k 1.6×	2.0k 0.6×	1.8k 0.6×	2.7k 1.1×	232 0.1×	217	10.2k

Countries citing papers authored by Hideki Hasegawa

Since Specialization

Citations

This map shows the geographic impact of Hideki Hasegawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Hasegawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Hasegawa more than expected).

Fields of papers citing papers by Hideki Hasegawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Hasegawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Hasegawa. The network helps show where Hideki Hasegawa may publish in the future.

Co-authorship network of co-authors of Hideki Hasegawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Hasegawa. A scholar is included among the top collaborators of Hideki Hasegawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Hasegawa. Hideki Hasegawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tomita, Yuriko, Rika Mochizuki, Takuya Yano, et al.. (2025). Multiple Respiratory Virus Detection in Acute Respiratory Infection Patients in Mie Prefecture, Japan, 2021–2023. Viruses. 17(3). 331–331.

Kamiya, Mari, Hideyuki Iwai, Yoshio Suzuki, et al.. (2024). Necroptosis in alveolar epithelial cells drives lung inflammation and injury caused by SARS-CoV-2 infection. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(8). 167472–167472. 4 indexed citations

Sano, Kaori, Yayoi Kimura, Atsushi Goto, et al.. (2024). Cellular and humoral immunity and IgG subclass distribution after omicron XBB.1.5 monovalent vaccination in Japan. Vaccine. 42(26). 126452–126452. 1 indexed citations

Ishii, Hiroshi, Takushi Nomura, Masako Nishizawa, et al.. (2024). Prophylactic vaccination inducing anti-Env antibodies can result in protection against HTLV-1 challenge in macaques. Molecular Therapy. 32(7). 2328–2339.

Nakao, Ryoma, Satoru Hirayama, Takehiro Yamaguchi, et al.. (2023). A bivalent outer membrane vesicle-based intranasal vaccine to prevent infection of periodontopathic bacteria. Vaccine. 41(30). 4369–4383. 11 indexed citations

Takashita, Emi, Shinji Watanabe, Hideki Hasegawa, & Yoshihiro Kawaoka. (2022). Are twindemics occurring?. Influenza and Other Respiratory Viruses. 17(1). e13090–e13090. 6 indexed citations

Iwata‐Yoshikawa, Naoko, Tsuyoshi Sekizuka, Kaori Sano, et al.. (2022). A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection. Science Advances. 8(1). eabh3827–eabh3827. 31 indexed citations

Huddleston, John, John Barnes, Thomas Rowe, et al.. (2020). Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A/H3N2 evolution. eLife. 9. 40 indexed citations

Iida, Shun, Sohtaro Mine, Keiji Ueda, et al.. (2020). Suberoyl Bis-Hydroxamic Acid Reactivates Kaposi’s Sarcoma-Associated Herpesvirus through Histone Acetylation and Induces Apoptosis in Lymphoma Cells. Journal of Virology. 95(5). 5 indexed citations

10.

Takahashi, Toru, Kaori Sano, Tadaki Suzuki, et al.. (2020). Virus-infected peripheral blood plasmablasts in a patient with severe fever with thrombocytopenia syndrome. International Journal of Hematology. 113(3). 436–440. 7 indexed citations

11.

Nakano, Tetsuo, Hiroshi Fujita, Akira Ainai, et al.. (2020). Double-Stranded Structure of the Polyinosinic-Polycytidylic Acid Molecule to Elicit TLR3 Signaling and Adjuvant Activity in Murine Intranasal A(H1N1)pdm09 Influenza Vaccination. DNA and Cell Biology. 39(9). 1730–1740. 4 indexed citations

12.

Sanada, Takahiro, Naoki Yamamoto, Mohammad Enamul Hoque Kayesh, et al.. (2019). Intranasal vaccination with HBs and HBc protein combined with carboxyl vinyl polymer induces strong neutralizing antibody, anti-HBs IgA, and IFNG response. Biochemical and Biophysical Research Communications. 520(1). 86–92. 10 indexed citations

13.

Sano, Kaori, Akira Ainai, Shinji Saito, et al.. (2018). IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration. Human Vaccines & Immunotherapeutics. 14(6). 1351–1361. 41 indexed citations

14.

Takaki, Haruyuki, Shigeo Kure, Hiroyuki Oshiumi, et al.. (2017). Toll-like receptor 3 in nasal CD103+ dendritic cells is involved in immunoglobulin A production. Mucosal Immunology. 11(1). 82–96. 35 indexed citations

15.

Mine, Sohtaro, Shinichiro Ota, Kengo Kato, et al.. (2016). Establishing and characterizing a new primary effusion lymphoma cell line harboring Kaposi’s sarcoma–associated herpesvirus. Infectious Agents and Cancer. 11(1). 37–37. 12 indexed citations

16.

Tanaka, Michiko, et al.. (2012). Herpes Simplex Virus 1 VP22 Regulates Translocation of Multiple Viral and Cellular Proteins and Promotes Neurovirulence. Journal of Virology. 86(9). 5264–5277. 43 indexed citations

17.

Kawaguchi, Akira, Yasuko Orba, Takashi Kimura, et al.. (2009). Inhibition of the SDF-1α–CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice. Blood. 114(14). 2961–2968. 55 indexed citations

18.

Saijo, Masayuki, Yasushi Ami, Yuriko Suzaki, et al.. (2008). Diagnosis and Assessment of Monkeypox Virus (MPXV) Infection by Quantitative PCR Assay: Differentiation of Congo Basin and West African MPXV Strains. Japanese Journal of Infectious Diseases. 61(2). 140–142. 48 indexed citations

19.

Hasegawa, Hideki, Masashi Tatsumi, Kiyoko Ogawa‐Goto, et al.. (2002). Processing of the HTLV-II Envelope Precursor Glycoprotein gp63 by Furin Is Essential for Cell Fusion Activity. AIDS Research and Human Retroviruses. 18(17). 1253–1260. 4 indexed citations

20.

Lewis, Martha J., Fiona Mulcahy, Noreen Sheehy, et al.. (1999). High Rate of Human T Lymphotropic Virus Type IIa Infection in HIV Type 1-Infected Intravenous Drug Abusers in Ireland. AIDS Research and Human Retroviruses. 15(8). 699–705. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact